Website Header with Language Selector and Dropdowns
Watermark

Acrivastine Impurity 3


Catalog Number: Cl-ACVT-05
CAS No.: NA
Mol.F: C23H26N2O2
Mol.W: 362.5
Inv. Status: Custom Synthesis

Chemical Name: 1-((E)-3-(6-((E)-3-oxobut-1-en-1-yl)pyridin-2-yl)-3-(p-tolyl)allyl)pyrrolidine 1-oxide.

Country of Origin: India

Product Category: Acrivastine Impurities


Acrivastine Impurity 3 is identified by CAS No. NA and is chemically known as 1-((E)-3-(6-((E)-3-oxobut-1-en-1-yl)pyridin-2-yl)-3-(p-tolyl)allyl)pyrrolidine 1-oxide.

Acrivastine Impurity 3 is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Acrivastine.

Page Keywords: Buy Acrivastine Impurity 3 | Purchase Acrivastine Impurity 3 | Acrivastine Impurity 3 suppliers | Acrivastine Impurity 3 manufacturers | Acrivastine Impurity 3 price | Acrivastine Impurity 3 Importer | Acrivastine Impurity 3 Exporter

Enquiry Now

Personal Details

Product Details

Related Products

CAT No: Cl-ACVT-06
CAS No: 87849-01-2
Mol Wt: 350.5
Mol F: C22H26N2O2
Inv. Status: Custom Synthesis
CAT No: Cl-ACVT-01
CAS No: 87848-99-5
Mol Wt: 348.4
Mol F: C22H24N2O2
Inv. Status: Custom Synthesis
CAT No: Cl-ACVT-03
CAS No: NA
Mol Wt: 378.5
Mol F: C23H26N2O3
Inv. Status: Custom Synthesis
CAT No: Cl-ACVT-04
CAS No: NA
Mol Wt: 394.5
Mol F: C23H26N2O4
Inv. Status: Custom Synthesis
CAT No: Cl-ACVT-07
CAS No: 93962-64-2
Mol Wt: 366.5
Mol F: C22H26N2O3
Inv. Status: Custom Synthesis
CAT No: Cl-ACVT-08
CAS No: NA
Mol Wt: 362.5
Mol F: C23H26N2O2
Inv. Status: Custom Synthesis
CAT No: Cl-ACVT-09
CAS No: 2064110-23-0
Mol Wt: 380.4
Mol F: C22H24N2O4
Inv. Status: Custom Synthesis
CAT No: Cl-ACVT-10
CAS No: NA
Mol Wt: 348.4
Mol F: C22H24N2O2
Inv. Status: Custom Synthesis
CAT No: Cl-ACVT-02
CAS No: 1057138-89-2
Mol Wt: 348.4
Mol F: C22H24N2O2
Inv. Status: Custom Synthesis
Subscribe for news letter:
  

© Cleanchem Laboratories LLP. All Rights Reserved.